Cancer and COVID-19: Update from Penn’s Abramson Cancer Center
LIVECMEConferences & Symposia

Add to Calendar Cancer and COVID-19: Update from Penn’s Abramson Cancer Center 9/30/2020 5:45:00 PM 9/30/2020 8:45:00 PM America/New_York Virtual false MM/DD/YYYY


Date & Location
Wednesday, September 30, 2020, 5:45 PM - 8:45 PM, Virtual, Philadelphia , PA

Course Overview
The novel coronavirus that causes COVID-19 infection is rapidly becoming one of the most challenging public health crises in modern history. But how is this pandemic specifically affecting cancer care, and what do clinicians need to know today to ensure they are providing the best care to their patients with cancer? Despite the negative impacts of COVID-19, the pandemic has hastened innovative changes such as telehealth, and access to home infusions. This activity is designed to focus on the major areas in which the COVID-19 pandemic has impacted how cancer care is delivered and experienced by patients. Participate in this live webcast and join the discussion on this fast moving subject while gaining up-to-date, practical information with immediate clinical and operational application.

Target Audience
Specialties - EMERGENCY MEDICINE, EMERGENCY MEDICINE - Hospice and Palliative Medicine, EMERGENCY MEDICINE - Internal Medicine-Critical Care Medicine, FAMILY MEDICINE, INTERNAL MEDICINE, INTERNAL MEDICINE - Endocrinology, Diabetes and Metabolism, INTERNAL MEDICINE - Gastroenterology, INTERNAL MEDICINE - Geriatric Medicine, INTERNAL MEDICINE - Hematology, INTERNAL MEDICINE - Hospice and Palliative Medicine, INTERNAL MEDICINE - Infectious Disease, INTERNAL MEDICINE - Medical Oncology, INTERNAL MEDICINE - Pulmonary Disease, NEUROLOGICAL SURGERY, OBSTETRICS AND GYNECOLOGY - Gynecologic Oncology, OTOLARYNGOLOGY, PATHOLOGY - CLINICAL, PATHOLOGY - Cytopathology, PATHOLOGY - Hematopathology, PATHOLOGY - Pathology-Chemical, PATHOLOGY - Pathology-Medical Microbiology, PUBLIC HEALTH AND GENERAL PREVENTIVE MEDICINE, SURGERY, SURGERY - Complex General Surgical Oncology, THORACIC AND CARDIAC SURGERY, UROLOGY


Objectives
  1. Identify the risk of infection with the novel coronavirus and severity of illness with COVID-19 in populations of patients with hematologic and solid tumor malignancies
  2. Define optimal protocols for cancer facilities, in both inpatient and outpatient settings, to minimize the risk of coronavirus infection
  3. Assess strategies to optimize treatment protocols for patients with cancer in light of the COVID-19 pandemic

Registration

For course information and registration, https://www.med.upenn.edu/MEDCOVID19/

For more information, contact Hyacen Putmon


Accreditation
In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  
 
Designation of Credit
Physicians: Penn Medicine designates this live activity for a maximum of 2.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credits
AMA PRA Category 1 Credits™ (2.75 hours), Non-Physician Attendance / Participation (2.75 hours)